Atom Investors’s Asensus Surgical, Inc. ASXC Stock Holding History

Atom Investors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,453	Closed	-$79K	–	352
2021 Q1	$79K	Buy	+24,453	New	+$88.6K	0.01%	233

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atom Investors's ASXC Position: Q2 2021 in Review

Atom Investors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2021, closing a stake of 24,453 shares — an estimated $79K sold.

Atom Investors first reported a position in ASXC in Q1 2021 and held it in 1 quarter. The position peaked at $79K in Q1 2021. 119 funds tracked by Wall St. Rank hold ASXC as of Q2 2021.

Atom Investors reported no remaining Asensus Surgical, Inc. position as of Q2 2021 after selling out during the quarter.
Atom Investors sold 24,453 Asensus Surgical, Inc. shares in Q2 2021, an estimated $79K.
Atom Investors first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 1 quarter.
Atom Investors's Asensus Surgical, Inc. position peaked at $79K in Q1 2021.
119 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2021.

Based on Atom Investors's 13F filing for Q2 2021, filed 16 Aug 2021.